Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #114914
advertisement
Marri S
15
Showing records 1 to 15 |
Display all abstracts from
Marri S
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Kilbile JT
ChemMedChem
2024; 19: e202400601
122419
Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Sgambellone S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 180: 117454
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Sapkal SB
ChemMedChem
2024; 19: e202400601
122419
Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Khanfar MA; Marri S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 180: 117454
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Renzi G; D'Agostino I
ChemMedChem
2024; 19: e202400601
122419
Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Villano S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 180: 117454
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Boudjelal M
ChemMedChem
2024; 19: e202400601
122419
Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Nardini P; Frank A
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 180: 117454
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Tamboli Y
ChemMedChem
2024; 19: e202400601
122419
Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Reiner-Link D
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 180: 117454
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Cutarella L; Mori M
ChemMedChem
2024; 19: e202400601
122419
Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Stark H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 180: 117454
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Sgambellone S
ChemMedChem
2024; 19: e202400601
122419
Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Lucarini L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 180: 117454
120751
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Villano S; Marri S; Lucarini L; Carradori S; Carta F; Supuran CT
ChemMedChem
2024; 19: e202400601
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept